HC blocks launch of Reliance breast cancer drug till Nov 17
Noting "serious issues" in a plea opposing Reliance Life Sciences' move to launch a breast and gastric cancer drug allegedly similar to that made by Swiss pharma major Roche's subsidiary Genentech Inc., Delhi High Court has directed the Indian firm not to release the product in the market till the next date of hearing.
Nov 05, 2015, 18:07 PM IST